Explore By Subject Area   

Immuno-Oncology 360°

Date: Mar 24, 2025 - Mar 26, 2025

Location: Boston, MA

Day One: Monday, March 24, 2025
Showing Events in 1 Track from 07:30am to 08:15am
Morning Remarks Grand Ballroom
Showing Events in 1 Track from 08:15am to 08:40am
Opening Keynote Grand Ballroom
Showing Events in 1 Track from 08:40am to 09:20am
Morning Session Grand Ballroom
Showing Events in 1 Track from 09:20am to 10:00am
Grand Opening of the IO360° Networking Café
Showing Events in 1 Track from 10:00am to 11:15am
New Technologies in Transformational Biology Plenary Grand Ballroom
Track Chair:
Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics
Showing Events in 2 Tracks from 11:15am to 12:30pm
Track 1: IO Novel Technologies Showcase A Grand Ballroom
Track Chair:
David Leung, MD, PhD, Head of Imaging, Daiichi Sankyo
Track 2: IO Novel Technologies Showcase B Back Bay Ballroom AB
Track Chair:
Dinesh de Alwis, PhD, SVP, Clinical Drug Development, Generate Biomedicines
Showing Events in 2 Tracks from 12:30pm to 01:45pm
Lunch & One-on-One Meetings Begin
Women Leaders in IO Luncheon & Panel Discussion - Pre-Registration with Ticket Required Constitution Ballroom AB
Showing Events in 2 Tracks from 01:45pm to 03:20pm
Track 1: New Tech in Transformational Biology (continued) Grand Ballroom
Track Chair:
James Gulley, MD, PhD, FACP, Co-Director, Center for Immuno-Oncology, CCR & Clinical Director, National Cancer Institute, NIH
Track 2: Oncology Clinical Operations Back Bay Ballroom AB
Track Chair:
Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck & Co., Inc.
Carol Haddad, Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1 Track from 03:20pm to 04:00pm
Afternoon Networking Break
Showing Events in 2 Tracks from 04:00pm to 06:10pm
Track 1: Breakthroughs in Translational Science, Imaging and Biomarkers (Pt 1) Grand Ballroom
Track Chair:
Marisa Dolled-Filhart, PhD, Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Track 2: Oncology Clinical Operations (continued) Back Bay Ballroom AB
Track Chair:
Carol Haddad, Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1 Track from 06:00pm to 07:00pm
11th Annual Networking Reception & One-on-One Meetings
Showing Events in 1 Track from 09:20am to 10:00am
Grand Opening of the IO360° Networking Café
Showing Events in 2 Tracks from 01:45pm to 03:20pm
Track 2: Oncology Clinical Operations
Back Bay Ballroom AB
Track Chair:
Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck & Co., Inc.
Carol Haddad, Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1 Track from 03:20pm to 04:00pm
Showing Events in 2 Tracks from 04:00pm to 06:10pm
Track 1: Breakthroughs in Translational Science, Imaging and Biomarkers (Pt 1)
Grand Ballroom
Track Chair:
Marisa Dolled-Filhart, PhD, Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Track 2: Oncology Clinical Operations (continued)
Back Bay Ballroom AB
Track Chair:
Carol Haddad, Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1 Track from 06:00pm to 07:00pm
11th Annual Networking Reception & One-on-One Meetings

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.